Table 3—
Estimated annual per-person diabetes complication costs in Medicare beneficiaries with type 2 diabetes
| Complication | Estimated costs, 2017 U.S. $ |
|---|---|
| Short-term | |
| Hypoglycemia | 9,399.2 |
| Ketoacidosis | 13,015.7 |
| Microvascular | |
| Nephropathy | 9,576.0 |
| Nephropathy history | 1,875.2 |
| Kidney failure treated by dialysis | 54,739.2 |
| Kidney failure treated by dialysis history | 38,621.6 |
| Kidney failure treated by transplant | 79,859.8 |
| Kidney failure treated by transplant history | 15,568.1 |
| Neuropathy | 4,561.9 |
| Neuropathy history | 870.7 |
| Foot ulcer | 10,433.3 |
| Foot ulcer history | 2,303.7 |
| LEA | 39,617.7 |
| LEA history | 7,506.0 |
| Chronic retinopathy | 681.8 |
| Chronic retinopathy history | (0.1) |
| Retinopathy intravitreal injections | 4,011.3 |
| Photocoagulation | 1,558.3 |
| Blindness and vision loss | 6,511.1 |
| Blindness and vision loss history | 446.9 |
| Macrovascular complications | |
| CHF | 12,476.0 |
| CHF history | 2,990.8 |
| MI | 18,981.5 |
| MI history | 1,602.5 |
| Stroke | 12,442.0 |
| Stroke history | 159.9 |
| Angina | 5,240.1 |
| Angina history | 541.7 |
| Revascularization | 11,300.6 |
| Revascularization history | 575.8 |